SFI
VTYX

Susquehanna Fundamental Investments’s Ventyx Biosciences VTYX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,777
Closed -$64.6K – 704
2025
Q3 		$64.6K Sell
20,777
-26,630
-56% -$70.6K ﹤0.01% 543
2025
Q2 		$101K Sell
47,407
-134,442
-74% -$217K ﹤0.01% 696
2025
Q1 		$209K Sell
181,849
-17,098
-9% -$29.4K ﹤0.01% 992
2024
Q4 		$436K Buy
+198,947
New +$451K 0.01% 879

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna Fundamental Investments's VTYX Position: Q4 2025 in Review

Susquehanna Fundamental Investments sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 20,777 shares — an estimated $64.6K sold.

Susquehanna Fundamental Investments first reported a position in VTYX in Q4 2024 and held it in 4 quarters. The position peaked at $436K in Q4 2024. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Susquehanna Fundamental Investments reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 20,777 Ventyx Biosciences shares in Q4 2025, an estimated $64.6K.
  • Susquehanna Fundamental Investments first reported a position in Ventyx Biosciences in Q4 2024 and held it in 4 quarters.
  • Susquehanna Fundamental Investments's Ventyx Biosciences position peaked at $436K in Q4 2024.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2025, filed 17 Feb 2026.